SCHEMBL30830570

SCHEMBL30830570

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCC(Oc4ccc(F)c(C5CCC(=O)NC5=O)c4)CC3)cc2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 12/20 0.47
▸ BRD9 Q9H8M2 3/20 0.47
▸ BRD1 O95696 1/20 0.47
▸ ACHE P22303 1/20 0.47
▸ BRPF1 P55201 1/20 0.47
▸ BPTF Q12830 1/20 0.47
▸ KAT2A Q92830 1/20 0.47
▸ BRD7 Q9NPI1 1/20 0.47
▸ BAZ2B Q9UIF8 1/20 0.47
▸ BRPF3 Q9ULD4 1/20 0.47
▸ HRH3 Q9Y5N1 2/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ DDB1 Q16531 2/20 0.31
▸ CRBN Q96SW2 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830638 0.93 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830652 0.92 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830729 0.90 KAT2B (0.52) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830987 0.90 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830815 0.89 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830696 0.89 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830942 0.88 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830854 0.87 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830614 0.86 KAT2B (0.53) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830684 0.86 KAT2B (0.56) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback